Immunohistochemical testing for Helicobacter Pyloriexistence in neoplasms of the colon
Tóm tắt
Helicobacter pylori is a common pathogen, and its prevalence varies with socioeconomic conditions (10–80%). It has recently been recognized as a class I carcinogen in relation to gastric cancer. The aim of this study was to investigate the presence of Helicobacter pylori in neoplasms of the colon by immunohistochemical methods. The polypectomy materials of 51 patients (19 male and 32 female) who had undergone colonoscopic polypectomy were retrieved for retrospective examination. The endoscopic size and colonic localization of the polyps were recorded. Hematoxylin and eosin stains were evaluated according to histological type and grade of dysplasia. Biopsy stains were immunohistochemically treated with Helicobacter pylori antibodies by the streptavidine-biotin immunoperoxidase technique. Helicobacter pylori staining in the gastric mucosa was used as the control for the immunohistochemical method. Specimens were classified according to the presence of Helicobacter pylori under an optical microscope, and Helicobacter pylori positive specimens were stratified according to the respective staining pattern. Mean age was 61.88 ± 10.62 (40–82) years. Polyp sizes were 1.45 ± 0.92 (1–4) cm; and 25.5% of polyps were localized in the right colon, 68.6% in the left colon and 5.9% in the transverse colon. Presence of Helicobacter pylori was not correlated with localization (p > 0.05) or size of the polyps (p > 0.05). Eleven (21.6%) of all specimens included in the study were Helicobacter pylori positive by immunohistochemical methods. Of the Helicobacter pylori positive specimens, the staining pattern was diffuse: Equivocal in 90.9%, nonspecific with a finely granular type concentrated on the luminal surface in 90.9%, dot-like granular in 54.5%, and spiral in 9.1%. Of the tubular polyps, 17.9% were H. pylori positive, and the staining pattern was equivocal in 100%, luminal in 85.7%, and dot-like granular in 57.1%. Of the villous polyps, 60% were H. pylori positive, and the staining pattern was inconclusive in 66.7%, luminal in 100%, dot-like granular in 33.3%, and spiral in 33.3%. Of the cancerous cases, 25% were H. pylori positive and showed an equivocal, luminal, and dot-like granular staining pattern. No significant correlation was determined between histologic types and prevalence of H. pylori (p > 0.05). The presence of H. pylori in colon polyps did not yield any correlation with polyp size, colonic localization or histopathologic type. The higher rate of H. pylori positivity in villous polyps does not present a causal relationship. We were able to determine H. pylori existence in colon polyps by immunohistochemical methods, albeit with no statistical significance.
Tài liệu tham khảo
Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK: Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991, 325: 1127-1131.
Gologan A, Graham DY, Sepulveda AR: Molecular markers in Helicobacter pylori-associated gastric carcinogenesis. Clin Lab Med. 2005, 25: 197-222. 10.1016/j.cll.2004.12.002.
Nilsson HO, Taneera J, Castedal M, Glatz E, Olsson R, Wadström T: Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol. 2000, 38: 1072-1076.
Maggio-Price L, Treuting P, Zeng W, Tsang M, Bielefeldt-Ohmann H, Iritani BM: Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer Res. 2006, 66: 828-838. 10.1158/0008-5472.CAN-05-2448.
Bell SJ, Chisholm SA, Owen RJ, Borriello SP, Kamm MA: Evaluation of Helicobacter species in inflammatory bowel disease. Aliment Pharmacol Ther. 2003, 18: 481-486. 10.1046/j.1365-2036.2003.01703.x.
Erdman SE, Poutahidis T, Tomczak M, Rogers AB, Cormier K, Plank B, Horwitz BH, Fox JG: CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol. 2003, 162: 691-702.
Jones M, Helliwell P, Pritchard C, Tharakan J, Mathew J: Helicobacter pylori in colorectal neoplasm: is there an aetiological relationship?. World J Surg Oncol. 2007, 5: 51-10.1186/1477-7819-5-51.
Rao VP, Poutahidis T, Ge Z, Nambiar PR, Boussahmain C, Wang YY, Horwitz BH, Fox JG, Erdman SE: Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res. 2006, 66: 7395-7400. 10.1158/0008-5472.CAN-06-0558.
Breuer-Katschinski B, Nemes K, Marr A, Rump B, Leiendecker B, Breuer N, Goebell H: Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion. 1999, 60: 210-215. 10.1159/000007661.
Bulajic M, Stimec B, Jesenofsky R, Kecmanovic D, Ceranic M, Kostic N, Schneider-Brachert W, Lowenfels A, Maisonneuve P, Löhr JM: Helicobacter pylori in colorectal carcinoma tissue. Cancer Epidemiol Biomarkers Prev. 2007, 16: 631-633. 10.1158/1055-9965.EPI-06-1031.
Siddheshwar RK, Muhammad KB, Gray JC, Kelly SB: Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. Am J Gastroenterol. 2001, 96: 84-88. 10.1111/j.1572-0241.2001.03355.x.
Immunohistology Protocol, LabVision. [http://www.labvision.com/pdf/Immunochemistry.pdf]
Parsonnet J: Helicobacter pylori. Infect Dis Clin North Am. 1998, 12: 185-97. 10.1016/S0891-5520(05)70417-7.
Testino G, Cornaggia M, Valentini M: Helicobacter pylori, pre-neoplastic changes, gastric cancer: a point of view. Eur J Gastroenterol Hepatol. 1999, 11: 357-359. 10.1097/00042737-199903000-00024.
Craanen ME, Dekker W, Blok P, Ferwerda J, Tytgat GN: Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut. 1992, 33: 16-20. 10.1136/gut.33.1.16.
Fukuda K, Kuroki T, Tajima Y, Tsuneoka N, Kitajima T, Matsuzaki S, Furui J, Kanematsu T: Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis. 2002, 23: 1927-1931. 10.1093/carcin/23.11.1927.
Leong RW, Sung JJ: Review article: Helicobacter species and hepatobiliary diseases. Aliment Pharmacol Ther. 2002, 16: 1037-1045. 10.1046/j.1365-2036.2002.01282.x.
Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, Koren R, Yahav J: Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol. 2001, 96: 3406-3410. 10.1111/j.1572-0241.2001.05342.x.
Fireman Z, Trost L, Kopelman Y, Segal A, Sternberg A: Helicobacter pylori: seroprevalence and colorectal cancer. Isr Med Assoc J. 2000, 2: 6-9.
Mizuno S, Morita Y, Inui T, Asakawa A, Ueno N, Ando T, Kato H, Uchida M, Yoshikawa T, Inui A: Helicobacter pylori infection is associated with colon adenomatous polyps detected by high-resolution colonoscopy. Int J Cancer. 2005, 117: 1058-1059. 10.1002/ijc.21280.
Meucci G, Tatarella M, Vecchi M, Ranzi ML, Biguzzi E, Beccari G, Clerici E, de Franchis R: High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. J Clin Gastroenterol. 1997, 25: 605-607. 10.1097/00004836-199712000-00011.
Oiya H, Okawa K, Aoki T, Nebiki H, Inoue T: Cap polyposis cured by Helicobacter pylori eradication therapy. J Gastroenterol. 2002, 37: 463-466. 10.1007/s005350200067.
Akamatsu T, Nakamura N, Kawamura Y, Shinji A, Tateiwa N, Ochi Y, Katsuyama T, Kiyosawa K: Possible relationship between Helicobacter pylori infection and cap polyposis of the colon. Helicobacter. 2004, 9: 651-656. 10.1111/j.1083-4389.2004.00273.x.
Wang KX, Wang XF, Penq JL, Cui YB, Wang J, Li CP: Detection of serum anti-Helicobacter pylori immunoglobulin G in patients with different digestive malignant tumors. World J Gastroenterol. 2003, 9: 2501-2504.
Grahn N, Hmani-Aifa M, Fransén K, Söderkvist P, Monstein HJ: Molecular identification of Helicobacter DNA present in human colorectal adenocarcinomas by 16S rDNA PCR amplification and pyrosequencing analysis. J Med Microbiol. 2005, 54: 1031-1035. 10.1099/jmm.0.46122-0.
Moss SF, Neugut AI, Garbowski GC, Wang S, Treat MR, Forde KA: Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association. J Natl Cancer Inst. 1995, 87: 762-763. 10.1093/jnci/87.10.762.
Luzza F, Maletta M, Imeneo M, Monteleone G, Marasco R, Biancone L, Pallone F: Evidence against colonic mucosa colonisation by Helicobacter pylori. Lack of a specific antibody response in homogenates of rectal endoscopic biopsies. Ital J Gastroenterol. 1996, 28: 447-451.
Jang TJ, Kim JR, Kim DH: Adherence of Helicobacter pylori to areas of type II intestinal metaplasia in Korean gastric mucosa. Yonsei Med J. 1999, 40: 392-395.
Rotimi O, Cairns A, Gray S, Moayyedi P, Dixon MF: Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol. 2000, 53: 756-759. 10.1136/jcp.53.10.756.
Marzio L, Angelucci D, Grossi L, Diodoro MG, Di Campli E, Cellini L: Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy. Am J Gastroenterol. 1998, 93: 223-226. 10.1111/j.1572-0241.1998.00223.x.
Saito N, Sato F, Kato M, Takeda H, Sugiyama T, Asaka M: What does the positivity of a monoclonal antibody against H. pylori mean?. Helicobacter. 1998, 3: 143-
Chaput C, Ecobichon C, Cayet N, Girardin SE, Werts C, Guadagnini S, Prévost MC, Mengin-Lecreulx D, Labigne A, Boneca IG: Role of AmiA in the morphological transition of Helicobacter pylori and in immune escape. PLoS Pathog. 2006, 2: e97-10.1371/journal.ppat.0020097.
Shand AG, Taylor AC, Banerjee M, Lessels A, Coia J, Clark C, Haites N, Ghosh S: Gastric fundic gland polyps in south-east Scotland: absence of adenomatous polyposis coli gene mutations and a strikingly low prevalence of Helicobacter pylori infection. J Gastroenterol Hepatol. 2002, 17: 1161-1164. 10.1046/j.1440-1746.2002.02863.x.
Craanen ME, Blok P, Dekker W, Ferwerda J, Tytgat GN: Subtypes of intestinal metaplasia and Helicobacter pylori. Gut. 1992, 33: 597-600. 10.1136/gut.33.5.597.
Genta RM: Helicobacter pylori as a protomer of intestinal metaplasia and gastric cancer: an alluring hypothesis in search of evidence. Eur J Gastroenterol Hepatol. 1995, 7: 25-30.
Genta RM, Gürer IE, Graham DY, Krishnan B, Segura AM, Gutierrez O, Kim JG, Burchette JL: Adherence of Helicobacter pylori to areas of incomplete metaplasia in the gastric mucosa. Gastroenterology. 1996, 111: 1206-1211. 10.1053/gast.1996.v111.pm8898634.
Jung A, Vieth M, Maier O, Stolte M: Fundic gland polyps (Elster's cysts) of the gastric mucosa. A marker for colorectal epithelial neoplasia?. Pathol Res Pract. 2002, 198: 731-734. 10.1078/0344-0338-00328.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-230X/8/35/prepub